{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:22:09Z","timestamp":1792790529390,"version":"4.5.0"},"reference-count":57,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T00:00:00Z","timestamp":1774828800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007956","name":"Nanjing University of Chinese Medicine","doi-asserted-by":"publisher","award":["XPT 82204696"],"award-info":[{"award-number":["XPT 82204696"]}],"id":[{"id":"10.13039\/501100007956","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012165","name":"Key Technologies Research and Development Program","doi-asserted-by":"publisher","award":["2024YFA1209901"],"award-info":[{"award-number":["2024YFA1209901"]}],"id":[{"id":"10.13039\/501100012165","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012165","name":"Key Technologies Research and Development Program","doi-asserted-by":"publisher","award":["2024YFA1209900"],"award-info":[{"award-number":["2024YFA1209900"]}],"id":[{"id":"10.13039\/501100012165","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010574","name":"China Academy of Space Technology","doi-asserted-by":"publisher","award":["2022-QNRC1-04"],"award-info":[{"award-number":["2022-QNRC1-04"]}],"id":[{"id":"10.13039\/501100010574","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002839","name":"Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002839","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003347","name":"Fudan University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82204696"],"award-info":[{"award-number":["82204696"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82125037"],"award-info":[{"award-number":["82125037"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82402052"],"award-info":[{"award-number":["82402052"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82305052"],"award-info":[{"award-number":["82305052"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004193","name":"Nanjing University of Aeronautics and Astronautics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004193","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Pharmaceutica Sinica B"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.apsb.2026.03.051","type":"journal-article","created":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T13:16:15Z","timestamp":1775135775000},"page":"3934-3952","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Astragalus-derived nano-agonist potentiates chemotherapy by reducing tumor-suppressive macrophages"],"prefix":"10.1016","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-3371-0836","authenticated-orcid":false,"given":"Xuan","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3205-0665","authenticated-orcid":false,"given":"Yongbing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiwen","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengcheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueyi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hurong","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qichen","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2681-0349","authenticated-orcid":false,"given":"Jing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2044-3074","authenticated-orcid":false,"given":"Peng","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.apsb.2026.03.051_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115545","article-title":"Triple-negative breast cancer: epidemiology, molecular mechanisms, and modern vaccine-based treatment strategies","volume":"212","author":"Karim","year":"2023","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.apsb.2026.03.051_bib2","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13058-020-01296-5","article-title":"Triple-negative breast cancer molecular subtyping and treatment progress","volume":"22","author":"Yin","year":"2020","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.apsb.2026.03.051_bib3","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1007\/s11427-020-1714-8","article-title":"Triple-negative breast cancer: new treatment strategies in the era of precision medicine","volume":"64","author":"Wu","year":"2021","journal-title":"Sci China Life Sci"},{"key":"10.1016\/j.apsb.2026.03.051_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2019.102855","article-title":"Triple negative breast cancer: a thorough review of biomarkers","volume":"145","author":"da Silva","year":"2020","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.apsb.2026.03.051_bib5","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1200\/JCO.20.03399","article-title":"Neoadjuvant chemotherapy, endocrine therapy, and targeted therapy for breast cancer: ASCO guideline","volume":"39","author":"Korde","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.apsb.2026.03.051_bib6","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1038\/s41591-022-01930-z","article-title":"Genomic and transcriptomic determinants of response to neoadjuvant therapy in rectal cancer","volume":"28","author":"Chatila","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/j.apsb.2026.03.051_bib7","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S1470-2045(17)30777-5","article-title":"Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials","volume":"19","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.apsb.2026.03.051_bib8","first-page":"1809","article-title":"Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer","volume":"41","author":"Liedtke","year":"2023","journal-title":"Clin Oncol"},{"key":"10.1016\/j.apsb.2026.03.051_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.breast.2024.103712","article-title":"Platinum chemotherapy for early triple-negative breast cancer","volume":"75","author":"Mason","year":"2024","journal-title":"Breast"},{"key":"10.1016\/j.apsb.2026.03.051_bib10","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.3390\/ijms24032969","article-title":"Triple-negative breast cancer and predictive markers of response to neoadjuvant chemotherapy: a systematic review","volume":"24","author":"van den Ende","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.apsb.2026.03.051_bib11","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2022-071674","article-title":"Advances in systemic therapies for triple-negative breast cancer","volume":"381","author":"Leon-Ferre","year":"2023","journal-title":"BMJ"},{"key":"10.1016\/j.apsb.2026.03.051_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104683","article-title":"Tumor microenvironment: challenges and opportunities in targeting metastasis of triple negative breast cancer","volume":"153","author":"Deepak","year":"2020","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.apsb.2026.03.051_bib13","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13045-021-01223-x","article-title":"HLF regulates ferroptosis, development, and chemoresistance of triple-negative breast cancer by activating tumor cell\u2013macrophage crosstalk","volume":"15","author":"Li","year":"2022","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.apsb.2026.03.051_bib14","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41392-021-00484-9","article-title":"Targeting tumor-associated macrophages to synergize tumor immunotherapy","volume":"6","author":"Xiang","year":"2021","journal-title":"Signal Transduct Targeted Ther"},{"key":"10.1016\/j.apsb.2026.03.051_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2024.04.011","article-title":"Immunotherapy-activated T cells recruit and skew late-stage activated M1-like macrophages that are critical for therapeutic efficacy","volume":"42","author":"van Elsas","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.apsb.2026.03.051_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.583084","article-title":"Tumor-associated macrophages in tumor immunity","volume":"11","author":"Pan","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.apsb.2026.03.051_bib17","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s13046-022-02272-x","article-title":"Tumor-associated macrophages in cancer: recent advancements in cancer nanoimmunotherapies","volume":"41","author":"Kumari","year":"2022","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.apsb.2026.03.051_bib18","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001341","article-title":"Tumor-associated macrophages: potential therapeutic strategies and future prospects in cancer","volume":"9","author":"Li","year":"2021","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.apsb.2026.03.051_bib19","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/nm1246","article-title":"TLR activation triggers the rapid differentiation of monocytes into macrophages and dendritic cells","volume":"11","author":"Krutzik","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.apsb.2026.03.051_bib20","doi-asserted-by":"crossref","first-page":"12246","DOI":"10.1002\/anie.201204910","article-title":"Discovery of small-molecule inhibitors of the TLR1\/TLR2 complex","volume":"51","author":"Cheng","year":"2012","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1016\/j.apsb.2026.03.051_bib21","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1038\/s41467-019-10354-2","article-title":"A toll-like receptor agonist mimicking microbial signal to generate tumor-suppressive macrophages","volume":"10","author":"Feng","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2026.03.051_bib22","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/s41477-021-00863-8","article-title":"RNA-binding proteins contribute to small RNA loading in plant extracellular vesicles","volume":"7","author":"He","year":"2021","journal-title":"Nat Plants"},{"key":"10.1016\/j.apsb.2026.03.051_bib23","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1126\/science.aar4142","article-title":"Plants send small RNAs in extracellular vesicles to fungal pathogens to silence virulence genes","volume":"360","author":"Cai","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.apsb.2026.03.051_bib24","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1186\/s40425-019-0817-4","article-title":"Ginseng-derived nanoparticles alter macrophage polarization to inhibit melanoma growth","volume":"7","author":"Cao","year":"2019","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.apsb.2026.03.051_bib25","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.ymthe.2021.08.028","article-title":"Ginseng-derived nanoparticles potentiate immune checkpoint antibody efficacy by reprogramming the cold tumor microenvironment","volume":"30","author":"Han","year":"2022","journal-title":"Mol Ther"},{"key":"10.1016\/j.apsb.2026.03.051_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.155116","article-title":"Astragaloside IV inhibits AOM\/DSS-induced colitis-associated tumorigenesis via activation of PPAR\u03b3 signaling in mice","volume":"121","author":"Liang","year":"2023","journal-title":"Phytomedicine"},{"key":"10.1016\/j.apsb.2026.03.051_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2020.112797","article-title":"Anti-tumor effects and mechanisms of Astragalus membranaceus (AM) and its specific immunopotentiation: status and prospect","volume":"258","author":"Li","year":"2020","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.apsb.2026.03.051_bib28","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.ijbiomac.2019.09.189","article-title":"Characterization and anti-tumor bioactivity of astragalus polysaccharides by immunomodulation","volume":"145","author":"Li","year":"2020","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.apsb.2026.03.051_bib29","first-page":"171","article-title":"Volatile analysis in fresh and dried Astragali Radix","volume":"32","author":"Xu","year":"2011","journal-title":"Food Sci (N Y)"},{"key":"10.1016\/j.apsb.2026.03.051_bib30","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.fsi.2019.12.025","article-title":"Astragalus membranaceus nanoparticles markedly improve immune and anti-oxidative responses; and protection against Aeromonas veronii in Nile tilapia Oreochromis niloticus","volume":"97","author":"Elabd","year":"2020","journal-title":"Fish Shellfish Immunol"},{"key":"10.1016\/j.apsb.2026.03.051_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.114108","article-title":"Technology insight: Plant-derived vesicles-how far from the clinical biotherapeutics and therapeutic drug carriers?","volume":"182","author":"Cong","year":"2022","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.apsb.2026.03.051_bib32","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.annonc.2020.10.475","article-title":"Assessment of structural chromosomal instability phenotypes as biomarkers of carboplatin response in triple negative breast cancer: the TNT trial","volume":"32","author":"Sipos","year":"2021","journal-title":"Ann Oncol"},{"key":"10.1016\/j.apsb.2026.03.051_bib33","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1001\/jamaoncol.2020.7157","article-title":"Effect of adjuvant paclitaxel and carboplatin on survival in early triple-negative breast cancer","volume":"7","author":"Arora","year":"2021","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.apsb.2026.03.051_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1295257","article-title":"Tumor-associated macrophages: an effective player of the tumor microenvironment","volume":"14","author":"Basak","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.apsb.2026.03.051_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115811","article-title":"The potential role of formononetin in cancer treatment: an updated review","volume":"168","author":"Aliya","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.apsb.2026.03.051_bib36","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.7150\/thno.69424","article-title":"Platinum-based drugs for cancer therapy and anti-tumor strategies","volume":"12","author":"Zhang","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.apsb.2026.03.051_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.115323","article-title":"Cisplatin in cancer treatment","volume":"206","author":"Romani","year":"2022","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.apsb.2026.03.051_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2021.102283","article-title":"Platinum-based chemotherapy in early-stage triple negative breast cancer: a meta-analysis","volume":"100","author":"Saleh","year":"2021","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.apsb.2026.03.051_bib39","doi-asserted-by":"crossref","first-page":"6645","DOI":"10.1039\/C8DT00838H","article-title":"The side effects of platinum-based chemotherapy drugs: a review for chemists","volume":"47","author":"Oun","year":"2018","journal-title":"Dalton Trans"},{"key":"10.1016\/j.apsb.2026.03.051_bib40","doi-asserted-by":"crossref","first-page":"3300","DOI":"10.1016\/j.apsb.2022.12.022","article-title":"Plant-derived nanovesicles: further exploration of biomedical function and application potential","volume":"13","author":"Li","year":"2023","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2026.03.051_bib41","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.canlet.2019.02.048","article-title":"Mechanisms and therapeutic potentials of cancer immunotherapy in combination with radiotherapy and\/or chemotherapy","volume":"452","author":"Yu","year":"2019","journal-title":"Cancer Lett"},{"key":"10.1016\/j.apsb.2026.03.051_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2020.101435","article-title":"Memory CD8+ T cell responses to cancer","volume":"49","author":"Han","year":"2020","journal-title":"Semin Immunol"},{"key":"10.1016\/j.apsb.2026.03.051_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.155810","article-title":"Unraveling the pathogenesis of myelosuppression and therapeutic potential of natural products","volume":"132","author":"Nian","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.apsb.2026.03.051_bib46","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1056\/NEJMoa2028485","article-title":"Sacituzumab Govitecan in metastatic triple-negative breast cancer","volume":"384","author":"Bardia","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.apsb.2026.03.051_bib47","doi-asserted-by":"crossref","first-page":"e459","DOI":"10.1016\/S2352-3026(24)00077-2","article-title":"Immune effector cell-associated haematotoxicity after CAR T-cell therapy: from mechanism to management","volume":"11","author":"Rejeski","year":"2024","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.apsb.2026.03.051_bib48","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.apsb.2021.08.016","article-title":"Natural exosome-like nanovesicles from edible tea flowers suppress metastatic breast cancer via ROS generation and microbiota modulation","volume":"2","author":"Chen","year":"2022","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2026.03.051_bib49","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202207826","article-title":"Plant-derived vesicle-like nanoparticles as promising biotherapeutic tools: present and future","volume":"35","author":"Feng","year":"2023","journal-title":"Adv Mater"},{"key":"10.1016\/j.apsb.2026.03.051_bib50","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1186\/s12951-023-02161-1","article-title":"Panax notoginseng: derived exosome-like nanoparticles attenuate ischemia\u2013reperfusion injury via altering microglia polarization","volume":"1","author":"Li","year":"2023","journal-title":"J Nanobiotechnol"},{"key":"10.1016\/j.apsb.2026.03.051_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113687","article-title":"Splenic B cell-targeting lipid nanoparticles for safe and effective mRNA vaccine delivery","volume":"382","author":"Suzuki","year":"2025","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2026.03.051_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.copbio.2023.103049","article-title":"Immune response to the components of lipid nanoparticles for ribonucleic acid therapeutics","volume":"85","author":"Chen","year":"2024","journal-title":"Curr Opin Biotechnol"},{"key":"10.1016\/j.apsb.2026.03.051_bib53","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1401294","article-title":"Collaboration between a cis-interacting natural killer cell receptor and membrane sphingolipid is critical for the phagocyte function","volume":"15","author":"Karyu","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.apsb.2026.03.051_bib54","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1053\/j.gastro.2017.10.050","article-title":"Nanoliposome C6-Ceramide increases the anti-tumor immune response and slows growth of liver tumors in mice","volume":"4","author":"Li","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.apsb.2026.03.051_bib55","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1016\/j.celrep.2018.07.062","article-title":"Dual targeting of innate and adaptive checkpoints on tumor cells limits immune evasion","volume":"24","author":"Liu","year":"2018","journal-title":"Cell Rep"},{"key":"10.1016\/j.apsb.2026.03.051_bib56","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.it.2008.12.001","article-title":"Variation matters: TLR structure and species-specific pathogen recognition","volume":"30","author":"Werling","year":"2009","journal-title":"Trends Immunol"},{"key":"10.1016\/j.apsb.2026.03.051_bib57","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1182\/blood-2014-12-618678","article-title":"Microenvironmental interleukin-6 suppresses toll-like receptor signaling in human leukemia cells through miR-17\/19A","volume":"126","author":"Li","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.apsb.2026.03.051_bib58","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nature07623","article-title":"Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis","volume":"457","author":"Kim","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2026.03.051_bib59","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.jddst.2017.08.010","article-title":"Characterization and cytotoxicity of PLGA nanoparticles loaded with formononetin cyclodextrin complex","volume":"41","author":"Guo","year":"2017","journal-title":"Drug Deliv Sci Tec"}],"container-title":["Acta Pharmaceutica Sinica B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383526002169?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383526002169?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T22:20:51Z","timestamp":1783030851000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211383526002169"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":57,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S2211383526002169"],"URL":"https:\/\/doi.org\/10.1016\/j.apsb.2026.03.051","relation":{},"ISSN":["2211-3835"],"issn-type":[{"value":"2211-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Astragalus-derived nano-agonist potentiates chemotherapy by reducing tumor-suppressive macrophages","name":"articletitle","label":"Article Title"},{"value":"Acta Pharmaceutica Sinica B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apsb.2026.03.051","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.","name":"copyright","label":"Copyright"}]}}